EUVIMEDEUVIMED entdecken
Crossref

Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates

Judith Díaz-García, Marina Machado, Luis Alcalá, Elena Reigadas, Carlos Sánchez-Carrillo, Ana Pérez-Ayala, Elia Gómez-García de la Pedrosa, Fernando González-Romo, Paloma Merino, María Soledad Cuétara, Coral García-Esteban, Inmaculada Quiles-Melero und 9 weitere

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.08.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Judith Díaz-García und 20 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria G…. Hauptthemen laut MEDLINE: Antifungal Agents, Candida. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Antifungal susceptibility testing is mostly conducted on blood-cultured Candida spp isolates. Because the intra-abdominal cavity has been highlighted as a hidden echinocandin-resistant C. glabrata reservoir, we assessed whether testing sequential isolates from a given patient might increase the chances of detecting antifungal resistance. METHODS: Intra-abdominal initial and sequential isolates from the same species from patients included in the CANDIdaemia in MADrid study (January 2019 to June 2022) were studied. We assessed antifungal susceptibility to amphotericin B, azoles, anidulafungin, micafungin, and ibrexafungerp using European Committee on Antimicrobial Susceptibility Testing (EUCAST) methodology and molecularly characterized resistant isolates. RESULTS: We collected 308 isolates (C. albicans [n = 179/308; 58.1%], C. glabrata [n = 101/308; 32.8%], C. tropicalis [n = 17/308; 5.5%], and C. parapsilosis [n = 11/308; 3.6%]) from 112 patients distributed as incident (n = 125/308) and sequential (n = 183/308). Per patient resistance rates of fluconazole (13.4% [15/112] vs. 8% [9/112]); 5.4% proportions difference (95% CI, -2.7% to 13.5%, p 0.09) and echinocandins (8.9% [10/112] vs. 1.8% [2/112]); 7.1% proportions difference (95% CI; 1.2-12.9%; p 0.01) were higher when considering all available isolates than only incident isolates. Resistance was detected in 18 of 112 patients and would have been overlooked in 11 of 18 (61.1%) patients if only incident isolates had been studied. Of the patients who harboured fluconazole or echinocandin-resistant isolates, 14 of 15 and 8 of 10 had received or were receiving fluconazole or echinocandins, respectively. DISCUSSION: Testing sequential Candida isolates from intra-abdominal samples is required to detect antifungal resistance, particularly to echinocandins, in patients whose incident isolates turned out to be susceptible. Furthermore, patients with echinocandin-resistant infections had frequently used echinocandins and had common secondary resistance acquisition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidaHumansFluconazoleEchinocandinsAmphotericin BCandida albicansCandida parapsilosisCandida tropicalisCandida glabrataMicrobial Sensitivity TestsDrug Resistance, Fungal

Stichwörter der Autor:innen

Abdominal samplesCandidaEUCASTEchinocandinsFluconazoleResistance

Substanzen

Antifungal AgentsFluconazoleEchinocandinsAmphotericin B

Autor:innen und Institutionen

  • Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; CIBER Enfermedades Respiratorias-CIBER…
  • Microbiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Sanitaria del Hospital 12 de Octubre, Madrid, Spain.
  • Microbiology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
  • Clinical Microbiology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain; Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Microbiology Department, Hospital Universitario Severo Ochoa, Leganés, Spain.

Zitieren

APA

Díaz-García, J., Machado, M., Alcalá, L., Reigadas, E., Sánchez-Carrillo, C., Pérez-Ayala, A., Gómez-García de la Pedrosa, E., González-Romo, F., Merino, P., Cuétara, M. S., García-Esteban, C., Quiles-Melero, I., Zurita, N. D., Muñoz-Algarra, M., Durán-Valle, M. T., Martínez-Quintero, G. A., Sánchez-García, A., Muñoz, P., Escribano, P., …, & CANDIMAD study group (2023). Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.08.021

Vancouver

Díaz-García J, Machado M, Alcalá L, Reigadas E, Sánchez-Carrillo C, Pérez-Ayala A, et al. Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.08.021

BibTeX
@article{DazGarca2023,
  author = {Díaz-García, Judith and Machado, Marina and Alcalá, Luis and Reigadas, Elena and Sánchez-Carrillo, Carlos and Pérez-Ayala, Ana and Gómez-García de la Pedrosa, Elia and González-Romo, Fernando and Merino, Paloma and Cuétara, María Soledad and García-Esteban, Coral and Quiles-Melero, Inmaculada and Zurita, Nelly Daniela and Muñoz-Algarra, María and Durán-Valle, María Teresa and Martínez-Quintero, Gabriela Andrea and Sánchez-García, Aída and Muñoz, Patricia and Escribano, Pilar and Guinea, Jesús and CANDIMAD study group, CANDIMAD study group},
  title = {Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.08.021}
}
Kostenlos starten →